Author: OurCrowd

[Arbe Robotics in PR Newswire] Arbe Announces $23 Million Offering of Registered Ordinary Shares

Jun 7, 2023 |

TEL AVIV, Israel, June 7, 2023 /PRNewswire/ — Arbe Robotics Ltd. (Nasdaq: ARBE) (“Arbe”), a global leader in perception radar solutions, today announced that it has entered into a definitive agreement with the Special Situations Funds and certain existing shareholders to purchase $23 million of its registered ordinary shares at a public offering price of $1.95 per share reflecting a 10% discount to the average closing price for the 20-day trading period ending immediately prior to execution of the definitive securities purchase agreement. Read more...

Read More

[JumpCloud in BizWest] JumpCloud makes hire to replace retiring CRO

Jun 7, 2023 |

LOUISVILLE — JumpCloud Inc., a directory-as-a-service technology platform, has hired Brad Mirkovich as its new chief revenue officer. Mirkovich, who has held management roles at companies including Conga and Businessolver, will succeed Kevin Biggs, who is retiring at the end of the month, the Louisville firm said in a news release. Read...

Read More

[Ynsect in Feed and Additive] Ÿnsect reveals high-density genotyping chip for insect breeding

Jun 7, 2023 |

Ÿnsect has announced the creation of a genotyping chip named Axiom® YNS_Mol1, a world-first for insect breeding and a major step in the evolution of selection of larvae lines to produce insect-based proteins. This novel chip dedicated to the Tenebrio molitor mealworm will allow for selection based on the genomic diversity of the species. Made available to the wider scientific community, it represents a key element of Ÿnsect’s strategy, as well as a groundbreaking tool for fundamental research in the sector. Read more...

Read More

[OncoHost in The Times of Israel] New Israeli technology improves prediction of patient response to immunotherapy

Jun 7, 2023 |

Researchers at Ben-Gurion University of the Negev have developed a new bio-sensing technology that predicts cancer patients’ response to immune checkpoint inhibitor (ICI) immunotherapy. More accurate and easier to implement than current methods, the technology has the potential to improve the effectiveness of immunotherapy and spare patients toxicity and debilitating side effects. Read...

Read More